Navios Maritime Partners L.P. Reports Financial Results for the First Quarter Ended March 31, 2018
May 08, 2018 11:55 am UTC| Business
$53.1 million revenue$5.5 million net income$6.4 million net cash from operating activities$31.5 million Adjusted EBITDASale of two containerships for $67.0 millionQuarterly cash distribution of $0.02 per unit MONACO, May...
May 08, 2018 11:55 am UTC| Business
NEW YORK, May 08, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Avon Products, Inc....
The Wisconsin Insurance Plan Contracts with Marias Technology
May 08, 2018 11:53 am UTC| Business
COVINGTON, Ohio, May 08, 2018 -- Marias Technology, a provider of software testing, implementation, integrations, and more to the insurance industry, has been hired by The Wisconsin Insurance Plan to help implement —...
May 08, 2018 11:50 am UTC| Business
NEW YORK, May 08, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Park Hotels ...
Arch Therapeutics Provides Update on Study Initiation and 510(k)
May 08, 2018 11:50 am UTC| Business
FRAMINGHAM, Mass., May 08, 2018 -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of liquid, gel and solid hemostatic and wound care devices, today announced that it will initiate the...
Green Spirit Industries Inc. Completes Construction on Medicinal Cannabis Dispensary in Puerto Rico
May 08, 2018 11:50 am UTC| Business
DORADO, Puerto Rico, May 08, 2018 -- Green Spirit Industries Inc. (OTC Pink:GSRX) (“Green Spirit” or the “Company”) announced today that it has completed construction on another of its five previously announced...
TLC Ranks Top 5% Again in Corporate Governance Evaluations
May 08, 2018 11:45 am UTC| Business
TAIPEI, Taiwan, May 08, 2018 -- Taiwan Liposome Company, Ltd. (4152.TWO) (TLC), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to...